冠状动脉疾病患者的阿司匹林过敏:最新的审查和实际建议
Luigi Cappannoli1,2, Stefania Colantuono3, Francesco Maria Animati2
1Dipartimento di Scienze Cardiovascolari-CUORE, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Biomolecules
|October 26, 2024
概括
过敏性对乙撒利酸 (ASA) 的过敏性在治疗冠状动脉疾病 (CAD) 中带来了挑战. 本综述详细介绍了针对需要抗血小板治疗的患者的ASA挑战和脱敏等策略.
科学领域:
- 心脏病学 心脏病学
- 临床免疫学临床免疫学
背景情况:
- 乙盐酸 (ASA) 对于动脉样硬化冠状动脉疾病 (CAD) 的抗血小板治疗至关重要.
- 经常报告过敏性阿司匹林,使治疗复杂化,需要仔细评估.
- 区分真正的过敏症和不耐受症对于患者管理至关重要.
研究的目的:
- 审查CAD患者阿司匹林过敏症的病理生理学,临床表现,诊断和管理.
- 为临床医生管理患有CAD和阿司匹林过敏症的患者提供实用指南.
主要方法:
- 对已确定的证据进行最新的审查.
- 讨论诊断和治疗策略,包括ASA挑战和无敏化.
- 探索困难案例的替代管理策略.
主要成果:
- 有两种主要策略,即低剂量ASA挑战和脱敏,可以使ASA管理.
- 对于不适合挑战或脱敏的患者,可提供替代策略,尽管未经指南批准.
- 准确的诊断和适当的管理是确保持续抗血小板治疗的关键.
结论:
- 在CAD患者中治疗阿司匹林过敏症需要采取系统的方法.
- 挑战和降低ASA敏感度是已知的方法,对于复杂的案例有替代方法.
- 本综述为面对这种临床情景的心脏病学家提供了实际指导.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Angina IV: Management
495
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659


